US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

EOLS

Evolus (EOLS)

Evolus Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EOLS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/08/10	05 : 30	Business Wire	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EOLS	Evolus Inc
2024/08/01	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EOLS	Evolus Inc
2024/08/01	05 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EOLS	Evolus Inc
2024/08/01	05 : 05	Business Wire	Evolus Reports Second Quarter 2024 Results and Raises Full Year Revenue Guidance	NASDAQ:EOLS	Evolus Inc
2024/07/31	21 : 00	Business Wire	Evolus to Hold Investor Day on September 12, 2024	NASDAQ:EOLS	Evolus Inc
2024/07/30	21 : 00	Business Wire	Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia	NASDAQ:EOLS	Evolus Inc
2024/07/25	21 : 00	Business Wire	Evolus to Participate in the Canaccord Genuity 44th Annual Growth Conference	NASDAQ:EOLS	Evolus Inc
2024/07/17	21 : 00	Business Wire	Evolus to Report Second Quarter Financial Results on July 31, 2024	NASDAQ:EOLS	Evolus Inc
2024/07/01	21 : 00	Business Wire	Evolus Announces Appointment of Albert G. White III to Board of Directors	NASDAQ:EOLS	Evolus Inc
2024/06/24	21 : 00	Business Wire	Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for First Two Evolysse™ Dermal Filler Products	NASDAQ:EOLS	Evolus Inc
2024/06/12	21 : 00	Business Wire	Evolus Broadens International Presence with Launch of Nuceiva® (botulinum toxin type A) in Spain	NASDAQ:EOLS	Evolus Inc
2024/06/12	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EOLS	Evolus Inc
2024/06/08	06 : 00	Business Wire	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EOLS	Evolus Inc
2024/06/07	08 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/06/07	06 : 45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EOLS	Evolus Inc
2024/06/06	10 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/06/06	06 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EOLS	Evolus Inc
2024/06/05	05 : 25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EOLS	Evolus Inc
2024/06/04	06 : 53	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EOLS	Evolus Inc
2024/05/20	21 : 30	Business Wire	Evolus Announces Positive Data from Pivotal Trial for First Two Evolysse™ Dermal Filler Products at 2024 SCALE Meeting	NASDAQ:EOLS	Evolus Inc
2024/05/16	06 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/05/15	21 : 30	Business Wire	Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit	NASDAQ:EOLS	Evolus Inc
2024/05/15	09 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/05/15	09 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EOLS	Evolus Inc
2024/05/15	09 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EOLS	Evolus Inc
2024/05/11	07 : 55	Business Wire	Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:EOLS	Evolus Inc
2024/05/10	22 : 10	Business Wire	Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year	NASDAQ:EOLS	Evolus Inc
2024/05/08	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EOLS	Evolus Inc
2024/05/08	05 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EOLS	Evolus Inc
2024/05/08	05 : 05	Business Wire	Evolus Reports First Quarter 2024 Results and Provides Business Update	NASDAQ:EOLS	Evolus Inc

Showing the most relevant articles for your search:NASDAQ:EOLS

1 2 3 4 5 6 7 8 9 10 次へ >>

Deutsche Telekom (QX)

Financial Select Sector

US Dollar vs Yen

US Dollar vs Euro

Energy Select Sector SPDR

Verizon Communications

Gold vs US Dollar

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約